Clinical trial
Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases
NCT04119115 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases
- Lead sponsor
- Corewell Health East
- Phase
- Observational
- Overall status
- Terminated
- Start date
- September 30, 2021
- Completion date
- October 20, 2022
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.